Application 215430
- Type
- NDA
- Sponsor
- AXSOME THERAPEUTICS, INC.
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AUVELITY | DEXTROMETHORPHAN HYDROBROMIDE AND BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 45MG/105MG | No | No |
| 002 | AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | TABLET, EXTENDED RELEASE;ORAL | 105MG;30MG | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 81968-045 | AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | Axsome Therapeutics, Inc. | NDA | Current |
| 81968-045 | AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | Axsome Therapeutics, Inc. | NDA | Current |
| 81968-045 | AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | Axsome Therapeutics, Inc. | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 85807 | SUPPL | 2026-05-12 |
| 85805 | SUPPL | 2026-05-12 |
| 85818 | SUPPL | 2026-05-06 |
| 85819 | SUPPL | 2026-05-04 |
| 85806 | SUPPL | 2026-05-01 |
| 84097 | SUPPL | 2025-11-06 |
| 84096 | SUPPL | 2025-11-06 |
| 84092 | SUPPL | 2025-11-06 |
| 78921 | ORIG | 2024-06-27 |
| 78431 | SUPPL | 2024-05-08 |
| 78420 | SUPPL | 2024-05-07 |
| 71853 | ORIG | 2022-08-19 |
| 71851 | ORIG | 2022-08-19 |
| 71849 | ORIG | 2022-08-19 |